Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Praxis Precision Medicines, Inc. (PRAX) had Free Cash Flow per Share of $-5.66 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-83.72M |
|
-- |
|
-- |
|
$96.90M |
|
$-96.90M |
|
$13.18M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-83.72M |
|
$-96.90M |
|
$-97.56M |
|
29.13M |
|
29.13M |
|
$-2.87 |
|
$-2.87 |
|
| Balance Sheet Financials | |
$771.90M |
|
$0.49M |
|
$618.20M |
|
$1.39B |
|
$49.06M |
|
-- |
|
-- |
|
$49.06M |
|
$1.34B |
|
$1.34B |
|
$1.34B |
|
27.92M |
|
| Cash Flow Statement Financials | |
$-163.69M |
|
$-333.29M |
|
$614.00M |
|
$357.75M |
|
$474.76M |
|
$117.02M |
|
$28.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.73 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-164.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.24% |
|
-6.25% |
|
-6.02% |
|
-6.24% |
|
$48.04 |
|
|
Free Cash Flow per Share |
$-5.66 |
$-5.62 |
|